Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMRA (Biomerica) -- Ignore unavailable to you. Want to Upgrade?

To: fossilg who wrote (133)	3/3/1999 8:56:00 AM
From: Walt	Respond to of 170

NEWS Biomerica Debuts Website to Market Home Health Tests; Announces That it Will Use E-Commerce to Sell Direct to Consumers Wednesday, March 3, 1999 08:22 AM Mail this article to a friend new! NEWPORT BEACH, Calif., March 3 /PRNewswire/ -- Biomerica, Inc. (Nasdaq: BMRA) today announced the debut of its Web site, testathome.com, to market home medical tests directly to consumers. This is part of Biomerica's soon to be introduced HomeDrugStore.com division, which will market a broad range of medical products to assist consumers with conditions or diseases requiring a constant supply of medical products for use in the home. "We have an aggressive schedule for using E-Commerce to introduce our medical products and services to a national audience via the Internet," said Zackary S. Irani, Biomerica Chief Executive Officer. "The products that will be sold at TESTatHOME.com are technically advanced yet simple to use. For example, the Drugs of Abuse test, available at the Web site, can detect if any one of six commonly abused drugs were used in the last 90 days by analyzing one human hair." Home health products currently available at TESTatHOME.com include tests for HIV-1 (AIDS), colorectal disease, including cancer, urinary tract infection, pregnancy and ovulation, bladder disease, skin growth, cholesterol and drugs of abuse. The site will soon add diabetic tests and supplies. All the products sold at TESTatHOME.com have been highly rated by scientists for effectiveness and ease of use. The products can be used in the privacy of the consumers' home and have been cleared by the U.S. Food and Drug Administration for such use. Mr. Irani said the HomeDrugStore.com site is different from other online drug store sites since it targets select individuals with long term medical conditions, such as cancer or diabetes, that require a constant supply of medical products. Patients or their families will be able to set up "recurring" orders, to have supplies delivered to their home, on a particular day on a continual basis. HomeDrugStore will, at no charge, also bill insurance companies for certain items. "HomeDrugStore plans to provide an important service to these consumers and their families, helping them obtain needed products, at a low cost, delivered directly to their homes and also assisting them with insurance billing. We are pleased that we will be able to offer this help to people with long term health needs," Mr. Irani said. Irani said Biomerica plans to market the sites through links with other online entities, monthly contests, including free shopping sprees, and advertising. The company also plans to build associations with other online companies. More than 320 million people will use the Internet in the new millennium and 40 percent of these will make online purchases, according to Internet experts. These experts also say that almost half of all current Internet users search for online health information. "This makes the Internet an ideal place to sell products related to healthcare," Irani said. Biomerica (Nasdaq: BMRA) is a global medical company devoted to developing, manufacturing and marketing advanced medical diagnostic products for the early detection of diseases. The products are used in hospitals, physicians' offices and in the home for self-testing. Except for historical information contained herein, the statements in this Press Release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, the continued demand for the Company's products, availability of raw materials and the state of the economy. These and other risks are described in the Company's Annual Report on Form 10-KSB and in the Company's other filings with the Securities and Exchange Commission. SOURCE Biomerica, Inc. CONTACT: Biomerica Investor Relations, 949-645-2111 Quote for referenced ticker symbols: BMRA © 1999, PR Newswire Help Center new! • Feedback • Channel Index • Channel Map • Glossary E-mail Newsletter • The Quicken Store • Quicken Support Help Add URL Advertise on Excite Press Releases Jobs@Excite Copyright © 1995-1999 Excite Inc. All rights reserved. Disclaimer © 1997-1999 Intuit Inc. All rights reserved. Trademark Notices By accessing and using this page you agree to the Terms of Service. Learn how important your privacy is to us. Walt